272
Participants
Start Date
November 10, 2017
Primary Completion Date
May 22, 2020
Study Completion Date
December 14, 2020
Evinacumab
SC or IV administration
Matching placebo
SC or IV administration
Background Lipid Modifying Therapy (LMT)
All participants should be on a stable, maximally tolerated statin throughout the duration of the study. The dose of statin and of PCSK9 inhibitor, such as alirocumab or evolocumab, as well as other LMT (if applicable), should remain stable throughout the study duration, from screening through the end of study (EOS) visit.
Jongaie Research, Pretoria
Dr JM Engelbrecht Trial Site, Cape Town
Redcliffe Hospital, Redcliffe
The Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg
Royal Prince Alfred Hospital, Camperdown
Clinical Horizons NZ Ltd, Tauranga
Papamoa Pines Medical Centre, Papamoa
University Hospital Innsbruck - Tyrolean Hospital, Innsbruck
Sydvestjysk Sygehus, Esbjerg
Regionshospitalet Herning, Herning
TREAD Research CC, Parow
University of Cape Town, Cape Town
Lipid and Diabetes Research Group, Christchurch
Mt Sinai Ichan Medical Institute, New York
Istishari Hospital, Amman
Akardo MedSite, Stockholm
CCR Prague, S.R.O, Prague
Hospital Universitario Reina Sofia, Córdoba
Ikem Institut Klinicke A Experimentalni Mediciny, Prague
Hospital Universitario A Coruna, A Coruña
Capital Area Research, LLC, Camp Hill
Hospital Universitario Virgen de las Nieves (HUVN), Granada
Houpital Du Bocage, Dijon
University of Maryland School of Medicine, Baltimore
King Abdullah University Hospital-1, Irbid
King Abdullah University Hospital-2, Irbid
King Abdullah University Hospital, Irbid
Duke University Medical Center, Durham
Rowan Diagnostic Clinic, Salisbury
Florida Lipid Institute, Winter Park
Care Research Center Inc, Doral
Preventive Cardiology Inc, Boca Raton
Cardiology Research Institute, Tomsk
Municipal Medical and Prophylactic Institution - City Hospital for Emergency Care No.2, Rostov-on-Don
Hospital Universitario Virgen del Rocio, Seville
Nzoz Przychodnia Specjalistyczna, Ruda Slaska
Hopital G Et R Laennec, Nantes
St. Vincent Medical Group, Inc, Indianapolis
Ausl Della Romagna-Ospedale Degli Infermi, Rimini
Heart Health Cardiology, Grand Rapids
University Hospital, Charles University, Hradec Králové
Hospital Universitario Miguel Servet, Zaragoza
Minneapolis Heart Institute Foundation, Minneapolis
University of Minnesota, Minneapolis
Fondazione Toscana Gabriele Monasterio Per La Ricerca Medica E Di Sanita Pubblica, Pisa
Edith Wolfson Medical Center, Holon
Washington University School of Medicine, St Louis
Sourasky Medical Center, Cardiovascular Research Center, Tel Aviv
Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovacsular Disease, Kemerovo
University of Kansas Medical Center, Kansas City
Akademiska sjukhuset, Uppsala
PharmaTex Research, Tyler
The University Of Texas Health Science Center Houston, Houston
Clear Clinical Research, LLC, Schertz
San Antonio Premiere Internal Medicine, San Antonio
Azienda Ospedaliero Universitaria Federico II di Napoli, Napoli
Wasatch Clinical Research, Salt Lake City
Cedars-Sinai Medical Center, Los Angeles
National Research Center For Preventative Medicine of Federal Agency of High Technology Medical Aid, Moscow
Federal State Budget Institution Out-patient Clinic 3, Moscow
Limmited Liability Company International Medical Centre SOGAZ, Saint Petersburg
Federal State Institution of Healthcare Clinical Hospital #122 N.A.L.G Sokolov, Saint Petersburg
LLC- Institute of Medical Research, Saint Petersburg
Federal State Budgetary Institution Clinical-Diagnostic Center with Polyclinic, Saint Petersburg
Samara Regional Clinical Cardiologic Dispensary, Samara
NII of Therapy and Preventive Medicine, Novosibirsk
Sheba Mc, Ramat Gan
Office of Dr. John D Homan MD, Newport Beach
EMMC Northeast Cardiology Assocites, Bangor
Massachusetts General Hospital, Boston
Medizinische Universitaetsklinik Graz, Graz
Robarts Research Institute, London
SKDS Research Inc., Newmarket
Centre Etudes Cliniques Econogene-21, Chicoutimi
Clinique des maladies lipidiques de Quebec, Québec
Univerzita Karlova v Praze 1 Lekarska Fakulta, Karlov
Galilee Medical Center, Nahariya
Universitair Medisch Centrum Utrech - Locatie AZU, Utrecht
Wojewodzki Szpital Specjalistyczny, Bytom
Karolinska University Hospital, Malmo
Dipartimento di Medicina Traslazionale e di Precisione dell'Università degli Studi di, Rome
Tokyo-Eki Center-building Clinic, Chūōku
Shonan Fujisawa Tokushukai Hospital, Fujisawa-shi
Minamino Cardiovascular Hospital, Hachiōji
Saitama Medical University Hospital, Iruma-gun
VOC Hoorn, Hoorn
Admiraal de Ruyter Ziekenhuis, Goes
Academic Medical Center, Amsterdam
M3 Helse AS, Oslo
Halina Serafin NZOZ Centrum Medyczne SERAFIN-MED, Żarów
Slaskie Centrum Chorob Serca, III Katedra i Oddzial Kliniczny Kardiologii SUM- Oddzial Chorob Serca i Naczyn, Zabrze
Hospital Universitario de Bellvitge, Barcelona
Karolinska Institutet, Stockholm
Royal Free Hospital-Royal Free London NHS Foundation Trust, London
Royal Victoria Infirmary - The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne
Regeneron Pharmaceuticals
INDUSTRY